Journal of Renal Medicine

contact@imedpub.com Submit a Manuscript

Renal Fibrosis

Tubulointerstitial fibrosis is a chronic and progressive process affecting kidneys during aging and in chronic kidney disease (CKD), regardless of cause. CKD and renal fibrosis affect half of adults above age 70 and 10% of the world's population. Although no targeted therapy yet exists to slow renal fibrosis, a number of important recent advances have clarified the cellular and molecular mechanisms underlying the disease. In this review, I highlight these advances with a focus on cells and pathways that may be amenable to therapeutic targeting. I discuss pathologic changes regulating interstitial myofibroblast activation, including profibrotic and proinflammatory paracrine signals secreted by epithelial cells after either acute or chronic injury. I conclude by highlighting novel therapeutic targets and approaches with particular promise for development of new treatments for patients with fibrotic kidney disease.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Awards Nomination 17+ Million Readerbase
Google Scholar citation report
Citations : 55

Journal of Renal Medicine received 55 citations as per Google Scholar report

image
Abstracted/Indexed in
  • Google Scholar
  • Secret Search Engine Labs

View More »

Open Access Journals